Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

NPPA Fixes Retail Prices of 62 Formulations, Details

Susmita Roy14 Sept 2024 6:00 PM IST

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, Government of...

CDSCO issues Cancelled permission List manufacturers

Susmita Roy11 Sept 2024 6:00 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has published a list of the details of manufacturers whose permissions have been...

Rajasthan Medical Council Suspends Licences of 8 Doctors for Submitting Forged Documents

CDSCO issues Cancelled Lincence List of importers

Susmita Roy9 Sept 2024 6:00 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has published a list of the details of importers whose permissions have been...

Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To Metronidazole

Susmita Roy4 Sept 2024 2:00 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of August, has revealed that the...

4 Diabetes Medication FDCs including Glimipride Metformin Strength banned by Health Ministry

156 FDCs banned with immediate effect, declared irrational: Ministry of Health and Family Welfare

Ruchika Sharma22 Aug 2024 6:00 PM IST

New Delhi: Citing that there is no therapeutic justification for the ingredients contained in fixed dose combinations (FDC) and that the FDC may...

Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To Vancomycin

Susmita Roy29 July 2024 6:00 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of July, has revealed that...

RML hospital warns doctors against unauthorized entry of pharma, diagnostic representatives

Susmita Roy11 July 2024 9:00 PM IST

New Delhi: Raising the issue of the increasing presence of unauthorized persons roaming around in hospital premises as agents of diagnostic services...

Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To amlodipine and acetazolamide

Susmita Roy4 July 2024 6:00 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of June, has revealed adverse drug...

Submit self declaration for FY 2024-2025 under UCPMP by June 30: Department of Pharmaceuticals

Susmita Roy4 Jun 2024 3:21 PM IST

New Delhi: Through a recent notice, the Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, the Government of India has written to...

Drug Safety Alert: IPC Flags ADR Linked To Cefuroxime, Nimesulide, Dutasteride plus Tamsulosin and some Beta-blockers

Susmita Roy14 April 2024 6:00 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert, has revealed adverse drug reactions linked with...

Delhi HC Upholds AstraZenecas Tagrisso Patent, Imposes Rs 7L Fine on Habitual Infringer for Knockoff Production

AstraZeneca to acquire Fusion Pharma to accelerate development of next-generation radioconjugates to treat cancer

Susmita Roy19 March 2024 4:11 PM IST

Cambridge: AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company...

Sun Pharma to acquire Checkpoint Therapeutics

Sun Pharma gets Australian regulatory nod for acne vulgaris treatment Winlevi

Susmita Roy19 March 2024 11:52 AM IST

Winlevi is approved for the topical treatment of acne vulgaris in people 12 years of age and older.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok